Published in Healthcare Finance, Tax and Law Weekly, June 10th, 2009
For the first time, the Prix Galien USA will be awarded in three categories that offer broad implications for future biomedical research: Best Pharmaceutical Agent, Best Biotechnology Product and Best Medical Device. All pharmaceutical and biological drugs or devices approved by the U.S. Food and Drug Administration for first or new indications between 1999...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.